MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 10-29-2024
10x Genomics Total Assets 2011-2026 | TXG
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets 10x Genomics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 965 M | 1.03 B | 1.02 B | 929 M | 606 M | 124 M | 75.6 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.03 B | 75.6 M | 678 M |
Quarterly Total Assets 10x Genomics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 938 M | 930 M | 923 M | - | - | 1.01 B | 1.03 B | - | 1 B | 1 B | 1.02 B | 991 M | 978 M | 954 M | 929 M | 929 M | 929 M | 929 M | 606 M | 606 M | 606 M | 606 M | 124 M | 124 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.03 B | 124 M | 818 M |
Total Assets of other stocks in the Health information services industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
476 M | - | 0.29 % | $ 206 M |  USA |
 |
Change Healthcare
CHNG
|
9.93 B | - | - | $ 9.03 B | USA |
 |
Cerner Corporation
CERN
|
7.43 B | - | - | $ 27.9 B | USA |
 |
American Well Corporation
AMWL
|
324 M | $ 5.55 | -1.42 % | $ 89.1 M | USA |
 |
Computer Programs and Systems
CPSI
|
434 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
3.41 B | - | - | $ 2.94 B | USA |
 |
Schrödinger
SDGR
|
726 M | $ 11.52 | 1.05 % | $ 846 M | USA |
 |
Phreesia
PHR
|
370 M | $ 11.52 | 2.49 % | $ 629 M | USA |
 |
Castlight Health, Inc.
CSLT
|
167 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
1.33 B | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
1.97 B | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
37.5 M | - | - | $ 102 M | USA |
 |
Teladoc Health
TDOC
|
2.86 B | $ 5.52 | -0.9 % | $ 973 M | USA |
 |
Evolent Health
EVH
|
1.82 B | $ 2.3 | 1.55 % | $ 216 M | USA |
 |
NextGen Healthcare
NXGN
|
644 M | - | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
2.63 B | - | - | $ 3.37 B | USA |
 |
MTBC
MTBC
|
87.6 M | - | -0.58 % | $ 51.7 M | USA |
 |
Premier
PINC
|
3.1 B | - | - | $ 2.33 B | USA |
 |
GoodRx Holdings
GDRX
|
1.39 B | $ 2.06 | -0.24 % | $ 795 M | USA |
 |
SCWorx Corp.
WORX
|
6.35 M | $ 0.14 | 7.38 % | $ 204 K | USA |
 |
Signify Health
SGFY
|
1.74 B | - | -0.02 % | $ 7.21 B | USA |
 |
R1 RCM
RCM
|
1.45 B | - | - | $ 3.81 B | USA |
 |
HealthStream
HSTM
|
511 M | $ 21.24 | 0.05 % | $ 645 M | USA |
 |
Akerna Corp.
KERN
|
7.63 M | - | - | $ 161 M | USA |
 |
Zhongchao
ZCMD
|
25.9 M | $ 1.78 | -1.11 % | $ 9.27 M |  China |
 |
Streamline Health Solutions
STRM
|
35.6 M | - | - | $ 21.4 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
2.43 B | - | -10.39 % | $ 886 M | USA |
 |
Health Catalyst
HCAT
|
503 M | $ 1.09 | -0.91 % | $ 76.2 M | USA |
 |
NantHealth
NH
|
160 M | - | -46.64 % | $ 10.4 M | USA |
 |
HealthEquity
HQY
|
3.38 B | $ 83.31 | 1.01 % | $ 7.18 B | USA |
 |
Omnicell
OMCL
|
2.12 B | $ 35.35 | 1.17 % | $ 1.63 B | USA |
 |
OptimizeRx Corporation
OPRX
|
183 M | $ 7.0 | -2.51 % | $ 120 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
384 M | - | - | $ 255 M | USA |
 |
Progyny
PGNY
|
607 M | $ 17.91 | 0.9 % | $ 1.54 B | USA |
 |
So-Young International
SY
|
2.74 B | $ 2.88 | -9.87 % | $ 229 M | China |
 |
Veeva Systems
VEEV
|
8.98 B | $ 180.16 | 1.17 % | $ 29.5 B | USA |